[ Price : $8.95]
A new House bill aims to close a loophole that is used by some brand drug makers to prevent potential generic drug firms from obta...[ Price : $8.95]
A special advisory bulletin from HHS Office of Inspector General raises concerns on the measures used by pharmaceutical manufactur...[ Price : $8.95]
FDA grants orphan drug status to Navidea Biopharmaceuticals for Lymphoseek Injection for sentinel lymph node detection in head and...[ Price : $8.95]
FDA assigns a user fee goal date for Salix Pharmaceuticals sNDA for Xifaxan for treating irritable bowel syndrome with diarrhea.[ Price : $8.95]
FDA awards the Critical Path Institute a second five-year grant that could total $10.5 million.[ Price : $8.95]
Attorney Suzanne OShea says Congress needs to clarify its intent so FDA knows how to classify combination products for review eith...[ Price : $8.95]
CDRH associate director for international affairs Kimberly A. Trautman says an FDA-backed medical device single audit program shou...[ Price : $8.95]
President Obamas science and technology advisors release a report and strategy on combating antibiotic resistance.